PL337003A1 - Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs - Google Patents
Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogsInfo
- Publication number
- PL337003A1 PL337003A1 PL98337003A PL33700398A PL337003A1 PL 337003 A1 PL337003 A1 PL 337003A1 PL 98337003 A PL98337003 A PL 98337003A PL 33700398 A PL33700398 A PL 33700398A PL 337003 A1 PL337003 A1 PL 337003A1
- Authority
- PL
- Poland
- Prior art keywords
- caprophen
- cox
- dogs
- selectively acting
- inflammatory states
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| PCT/IB1998/000662 WO1998050033A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL337003A1 true PL337003A1 (en) | 2000-07-31 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98337003A PL337003A1 (en) | 1997-05-05 | 1998-05-01 | Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (en) |
| JP (1) | JP2000513020A (en) |
| KR (2) | KR20040004406A (en) |
| CN (1) | CN1255059A (en) |
| AP (1) | AP9801234A0 (en) |
| AR (2) | AR011726A1 (en) |
| AU (1) | AU6932198A (en) |
| BG (1) | BG103852A (en) |
| BR (1) | BR9808720A (en) |
| CA (1) | CA2288759A1 (en) |
| DZ (1) | DZ2479A1 (en) |
| EA (1) | EA003696B1 (en) |
| GT (1) | GT199800063A (en) |
| HR (1) | HRP980244A2 (en) |
| HU (1) | HUP0001286A3 (en) |
| ID (1) | ID21311A (en) |
| IL (1) | IL132570A0 (en) |
| IS (1) | IS5220A (en) |
| MA (1) | MA26491A1 (en) |
| NO (1) | NO995389L (en) |
| NZ (1) | NZ500183A (en) |
| OA (1) | OA11213A (en) |
| PA (1) | PA8450601A1 (en) |
| PE (1) | PE72599A1 (en) |
| PL (1) | PL337003A1 (en) |
| SK (1) | SK148199A3 (en) |
| TN (1) | TNSN98059A1 (en) |
| TW (1) | TW590773B (en) |
| UY (1) | UY24989A1 (en) |
| WO (1) | WO1998050033A1 (en) |
| YU (1) | YU55899A (en) |
| ZA (1) | ZA983722B (en) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| US6506785B2 (en) | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| CA2347365A1 (en) * | 1998-10-23 | 2000-05-04 | Merck Frosst Canada & Co. | Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| EP1637137A3 (en) * | 1999-03-10 | 2006-07-05 | G.D. Searle LLC | Method and composition for administering a cyclooxygenase-2 inhibitor to animals |
| AU1592901A (en) * | 1999-11-11 | 2001-06-06 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| JP2004521856A (en) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Combination therapy using a COX-2 selective inhibitor and a thromboxane inhibitor and compositions therefor |
| AU6837701A (en) | 2000-06-13 | 2001-12-24 | American Home Prod | Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
| DE10032132A1 (en) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition |
| US20020106707A1 (en) | 2000-08-07 | 2002-08-08 | Marnett Lawrence J. | Compositions and methods for detecting and quantifying COX-2 activity and anandamide metabolites |
| US20040209959A1 (en) * | 2001-07-16 | 2004-10-21 | Edward Hogestatt | Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation |
| PT1534305E (en) | 2003-05-07 | 2007-02-28 | Osteologix As | Treating cartilage / bone conditions with water-soluble strontium salts |
| WO2005009436A1 (en) * | 2003-07-31 | 2005-02-03 | Pharmacia & Upjohn Company Llc | Dispersible formulation of an anti-inflammatory agent |
| EP1940380A2 (en) * | 2005-05-20 | 2008-07-09 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands |
| US8535713B2 (en) | 2007-04-04 | 2013-09-17 | Sigmoid Pharma Limited | Pharmaceutical cyclosporin compositions |
| US8951570B2 (en) | 2007-04-26 | 2015-02-10 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
| JP5640079B2 (en) | 2009-05-18 | 2014-12-10 | シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ | Oil droplet-containing composition |
| BR112012002963A2 (en) | 2009-08-12 | 2017-10-24 | Sigmoid Pharma Ltd | immunomodulatory compositions comprising a polymer matrix and an oil phase |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| CA2941008C (en) | 2014-03-06 | 2022-07-26 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| EP3215127B1 (en) | 2014-11-07 | 2020-10-28 | Sublimity Therapeutics Limited | Compositions comprising cyclosporin |
| BR112017014750A2 (en) * | 2015-01-09 | 2018-06-19 | Jaguar Animal Health | methods for treating diarrhea in pets |
| CN115335046A (en) * | 2020-03-25 | 2022-11-11 | 思研（Sri）国际顾问与咨询公司 | Lipoxygenase inhibitors |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (en) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | Pharmaceutical composition for preventing or treating keloid or hypertrophic scar comprising Benzbromarone |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/en active
- 1998-04-30 TW TW087106689A patent/TW590773B/en not_active IP Right Cessation
- 1998-05-01 CN CN98804845A patent/CN1255059A/en active Pending
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 YU YU55899A patent/YU55899A/en unknown
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/en not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/en not_active IP Right Cessation
- 1998-05-01 SK SK1481-99A patent/SK148199A3/en unknown
- 1998-05-01 IL IL13257098A patent/IL132570A0/en unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/en unknown
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 ID IDP980651A patent/ID21311A/en unknown
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/en not_active Application Discontinuation
- 1998-05-01 JP JP10547869A patent/JP2000513020A/en active Pending
- 1998-05-01 EA EA199900895A patent/EA003696B1/en not_active IP Right Cessation
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 PL PL98337003A patent/PL337003A1/en unknown
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-04 MA MA25059A patent/MA26491A1/en unknown
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/en unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/en not_active Application Discontinuation
- 1998-05-04 PE PE1998000335A patent/PE72599A1/en not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/en unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/en unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/en not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/en unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/en unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/en unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/en unknown
- 1999-11-04 NO NO995389A patent/NO995389L/en not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL337003A1 (en) | Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs | |
| PL336758A1 (en) | Substituted imidazoles useful in treating inflammatory states | |
| HUP0004484A3 (en) | Desaturase genes and their use | |
| EP0923690A4 (en) | Integrated power and control system | |
| DE69836460D1 (en) | Transmission device and load distribution transmission method in the transmission device | |
| PL337665A1 (en) | (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains | |
| GB9704162D0 (en) | Assay methods and means | |
| EP0980261A4 (en) | Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals | |
| GB2328299B (en) | Data-processing device and method | |
| AU5871898A (en) | Microparticles and their use in cancer treatment | |
| DE69628756D1 (en) | Combined longitudinal and transverse tracking | |
| GB9624587D0 (en) | Improvements in and relating magnetic bearings | |
| GB9625666D0 (en) | Improvements in construction and control | |
| ZA972543B (en) | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs | |
| GB9705561D0 (en) | Localized object and domestic cat locateing device | |
| BR7601188U (en) | Provision introduced in portfolio | |
| BR9705337A (en) | Improvements introduced in electric showers and other showers | |
| GB9726490D0 (en) | Hydraulic power arrangement and method | |
| GB9603168D0 (en) | Microorganisms and their use in treating silage | |
| BR7600753U (en) | Constructive arrangement in blender chipper - drive and drag system | |
| NL1005646A1 (en) | Method and device for reducing the current consumption in a plasma-addressed structure. | |
| AU1374599A (en) | Materials and methods for preventing cellular injury in humans and animals | |
| GB9818187D0 (en) | Improvements in and relating to access control | |
| BR9604588A (en) | Provisions introduced in forage wagon | |
| GB9818018D0 (en) | Microparticles and their use in therapy |